The Society for Immunotherapy of Cancer (SITC) hosted Session 208a during the 38th Annual Meeting & Pre-Conference Programs on Saturday, November 4, 2023. Available here are the presentation slides and video from “Session 208a: Neuroimmunology in Cancer” as permitted by presenters.
Robert Prins, PhD – University of California-Los Angeles
Sebastien Talbot, PhD – Queen's University
Despite new advances in immunotherapy for many solid tumors, tumors arising in the brain and around peripheral nerves are not typically immune responsive. Cancer cells actively secrete growth factors that promote tumor hyper-innervation (neo-neurogenesis) and develop complex connections with neurons and other parenchymal cells in the brain. A better understanding of how tumor cells develop immune resistance in these anatomical compartments is critical before immunotherapy may produce clinically relevant anti-tumor immunity. In this session, experts will discuss the latest research in the tumor innervation, brain metastases, and immunotherapy.
To view the entire program schedule (including presenter permission to post) please click here.
SITC 2023 Annual Meeting: Saturday, November 401:26:47